Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

109

A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoarthritis of the hip or knee, the companies said on Thursday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/Ly3ndsReaFA/lower-dose-of-pfizer-lilly-painkiller-misses-main-goals-in-late-stage-study-idUSKCN1RU2J4

- Advertisement -